About i-SENS
i-SENS is a company based in Zhangjiagang (China) founded in 2000.. The company has 81 employees as of April 03, 2024. i-SENS offers products and services including CareSens Air App, Blood Glucose Monitoring, Continuous Glucose Monitoring System, Point of Care, and Veterinary Care. i-SENS operates in a competitive market with competitors including Jana Care, Telcare, Intuity Medical, Hygieia and Ascensia, among others.
- Headquarter Zhangjiagang, China
- Employees 81 as on 03 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Isens Biosensors India Private Limited
- Date of Incorporation 27 Mar, 2015
- Jurisdiction Gurgaon, Haryana, India
-
Annual Revenue
$3.87 M (USD)6.52as on Mar 31, 2023
-
Net Profit
$368.23 K (USD)3.29as on Mar 31, 2023
-
EBITDA
$122.37 K (USD)-70.33as on Mar 31, 2023
-
Latest Funding Round
$149.9 K (USD), Grant
Aug 05, 2014
- Investors
-
Employee Count
81
as on Apr 03, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of i-SENS
i-SENS offers a comprehensive portfolio of products and services, including CareSens Air App, Blood Glucose Monitoring, Continuous Glucose Monitoring System, Point of Care, and Veterinary Care. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
App for real-time glucose tracking and data sharing.
Devices for measuring blood sugar levels accurately.
System for ongoing glucose level tracking.
Tools for immediate diagnostic testing.
Products for glucose monitoring in animals.
Unlock access to complete
Unlock access to complete
Funding Insights of i-SENS
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $149,902
-
First Round
First Round
(05 Aug 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2014 | Amount | Grant - i-SENS | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in i-SENS
i-SENS has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by i-SENS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - i-SENS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
I-Sens Comparisons
Competitors of i-SENS
i-SENS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jana Care, Telcare, Intuity Medical, Hygieia and Ascensia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Mobile-based diagnostics for diabetes prevention and management are provided.
|
|
| domain | founded_year | HQ Location |
Diabetes is managed via cellular technology and social networking.
|
|
| domain | founded_year | HQ Location |
An all-in-one blood glucose monitoring system is developed and offered.
|
|
| domain | founded_year | HQ Location |
Insulin dosage guidance for diabetes is provided via handheld devices.
|
|
| domain | founded_year | HQ Location |
Provides blood glucose monitoring systems and diabetes care solutions worldwide.
|
|
| domain | founded_year | HQ Location |
Manufacturer and Global seller of Blood glucose monitoring systems
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on I-Sens
Frequently Asked Questions about i-SENS
When was i-SENS founded?
i-SENS was founded in 2000 and raised its 1st funding round 14 years after it was founded.
Where is i-SENS located?
i-SENS is headquartered in Zhangjiagang, China. It is registered at Zhangjiagang, Jiangsu, China.
How many employees does i-SENS have?
As of Apr 03, 2024, the latest employee count at i-SENS is 81.
What is the annual revenue of i-SENS?
Annual revenue of i-SENS is $3.87M as on Mar 31, 2023.
What does i-SENS do?
i-SENS was founded in 2000 and is based in Zhangjiagang, China. Blood glucose monitoring systems, such as the CareSens model for sugar level detection, and clinical chemistry analyzers are produced by the company. A mobile application is provided for users to record and review blood glucose data. Operations center on diagnostic tools within the healthcare sector.
Who are the top competitors of i-SENS?
i-SENS's top competitors include Telcare, Jana Care and Intuity Medical.
What products or services does i-SENS offer?
i-SENS offers CareSens Air App, Blood Glucose Monitoring, Continuous Glucose Monitoring System, Point of Care, and Veterinary Care.
Who are i-SENS's investors?
i-SENS has 1 investor. Key investors include HHS.